Tuesday, May 31, 2016 9:35:52 AM
EXCERPT FROM 5/31/16 PR AS FOLLOWS:
SAN DIEGO, CA--(Marketwired - May 31, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA) is pleased to announce that its flagship product Real Scientific Hemp Oil™ (RSHO™) has been authorized by Paraguay's government for import into the country as a prescription medication for refractory epilepsy.
Paraguay's first-ever import permit for RSHO™ marks the fourth country in Latin America, after Brazil, Puerto Rico, and Mexico, to approve MJNA's cannabidiol (CBD) hemp oil for indications including epilepsy, Parkinson's disease, chronic pain, and cancer.
The first shipment of RSHO™ into Paraguay was authorized for 15-year-old Mathias Alejandro Gonzalez, who was diagnosed with an autism spectrum disorder and suffers from Lennox-Gastaut Syndrome (LGS), a rare type of epilepsy that doesn't respond well to seizure medications.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM